title: The immune pathogenesis of multiple sclerosis.
abstract: Multiple sclerosis is an autoimmune disease of the central nervous system (CNS) that leads to changes of nerve conduction due to damage of CNS- resident cells, primarily oligodendrocytes and neurons. CD4+ T cells are of primary importance in the immune cascades leading to tissue damage, but also CD8+ T cells, NK cells and B cells and antibodies contribute to tissue damage. In addition, the innate immune response and mainly microglial cells participate in the events leading to lesions. There are different types of MS and possibly this is due to different underlying immune mechanisms. The current treatment options mainly affect the immune response but have not much influence on secondary signaling changes in astrocytes and neurons which contribute to constant disease progression. The immune response in MS must be seen in the systemic context and there are strong indications that the gut and lung immunity affect MS disease precipitation. The strongest genetic influence in MS is mediated by the HLA class II genes and in Western Europeans and North Americans the disease is associated with HLA-DR2b. Possibly this is due to presentation of a set of specific antigens in context of this HLA allele. Novel data indicates that the immune response in MS is not only focused on certain myelin proteins like myelin basic protein (MBP) but to additional astrocytic and neuronal proteins, which is also mirrored in the pathology. While in the past the disease has been considered as mainly a white matter disease, nowadays it is clear that also grey matter is affected by the aberrant immune response. Still much needs to be learned regarding the underlying events in MS. This expanded knowledge is important to finally discover curative therapies.
authors: Department of Neurology, University of Regensburg, Universitaetsstrasse 84, 93053 Regensburg, Germany. robert.weissert@ukr.de
authors: Robert
authors: R
authors: Weissert
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology / Q000473:pathology; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D007167:Immunotherapy / Q000379:methods; D009103:Multiple Sclerosis / Q000209:etiology* / Q000276:immunology* / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology
references: Arch Neurol. 2012 Feb;69(2):239-45
references: 22332191
references: Annu Rev Immunol. 2009;27:119-45
references: 19302036
references: Cell. 1995 Mar 10;80(5):695-705
references: 7534214
references: Neurology. 1995 Jul;45(7):1268-76
references: 7617181
references: J Immunol. 2008 Mar 15;180(6):3866-73
references: 18322194
references: Arch Neurol. 2008 Nov;65(11):1443-8
references: 18779415
references: J Clin Invest. 1998 Sep 15;102(6):1265-73
references: 9739061
references: J Biol Chem. 2012 May 18;287(21):17206-17213
references: 22493449
references: Immunity. 2009 Mar 20;30(3):348-57
references: 19303388
references: Ann Neurol. 2001 Sep;50(3):389-400
references: 11558796
references: Nat Immunol. 2010 Jul;11(7):628-34
references: 20526343
references: N Engl J Med. 2012 Sep 20;367(12):1098-107
references: 22992073
references: Neurology. 2012 Nov 20;79(21):2140-5
references: 23170011
references: Neurology. 2011 Aug 9;77(6):580-8
references: 21795651
references: Neurology. 1993 Apr;43(4):655-61
references: 8469318
references: Hum Mol Genet. 2006 Sep 15;15(18):2813-24
references: 16905561
references: Immunity. 2001 Mar;14(3):291-302
references: 11290338
references: Neurology. 2013 Jan 15;80(3):246-52
references: 23269598
references: Neurology. 1996 Apr;46(4):907-11
references: 8780061
references: Brain Pathol. 2004 Apr;14(2):164-74
references: 15193029
references: Annu Rev Pathol. 2012;7:185-217
references: 22313379
references: Brain Pathol. 1996 Jul;6(3):275-88
references: 8864284
references: Int Immunol. 1999 Dec;11(12):1981-8
references: 10590264
references: N Engl J Med. 2008 Feb 14;358(7):676-88
references: 18272891
references: Ann Neurol. 2011 Feb;69(2):292-302
references: 21387374
references: Lancet Neurol. 2008 Mar;7(3):268-77
references: 18275928
references: Z Klin Chem Klin Biochem. 1971 Jul;9(4):334-6
references: 4142824
references: J Immunol. 2002 Aug 1;169(3):1550-5
references: 12133983
references: Nature. 2011 Aug 10;476(7359):214-9
references: 21833088
references: Curr Treat Options Neurol. 2005 May;7(3):173-182
references: 15814070
references: Mult Scler. 2012 Jan;18(1):113-5
references: 22146605
references: N Engl J Med. 2006 Mar 2;354(9):899-910
references: 16510744
references: J Immunol. 1998 Jan 15;160(2):681-90
references: 9551903
references: Cell Death Differ. 2010 Jul;17(7):1083-91
references: 19927157
references: Genes Immun. 2011 Oct;12(7):523-30
references: 21654846
references: J Neuroimmunol. 2002 Dec;133(1-2):20-9
references: 12446004
references: Lancet. 2004 Dec 11-17;364(9451):2106-12
references: 15589308
references: Nature. 2012 Aug 30;488(7413):675-9
references: 22914092
references: Brain. 2005 Nov;128(Pt 11):2705-12
references: 16230320
references: Trends Mol Med. 2011 Mar;17(3):119-25
references: 21251877
references: J Exp Med. 2006 Aug 7;203(8):1963-75
references: 16847068
references: Nature. 2011 Oct 26;479(7374):538-41
references: 22031325
references: J Neuroimmunol. 2011 Feb;231(1-2):73-7
references: 20937530
references: N Engl J Med. 2012 May 17;366(20):1870-80
references: 22591293
references: Immunol Rev. 2012 Jul;248(1):216-27
references: 22725964
references: Lancet. 2002 Dec 21-28;360(9350):2018-25
references: 12504397
references: Annu Rev Immunol. 2012;30:393-427
references: 22224765
references: Neurology. 2006 May 23;66(10):1485-9
references: 16717206
references: Annu Rev Neurosci. 2008;31:247-69
references: 18558855
references: Glia. 2000 Feb 15;29(4):293-304
references: 10652440
references: Brain. 2011 Mar;134(Pt 3):653-64
references: 21303861
references: Lancet. 2005 Aug 13-19;366(9485):579-82
references: 16099294
references: J Immunol. 2006 Dec 1;177(11):7750-60
references: 17114446
references: Ann Neurol. 2008 Jan;63(1):16-25
references: 18232012
references: J Immunol. 2001 Dec 15;167(12):7119-25
references: 11739534
references: Ann Neurol. 1996 Mar;39(3):285-94
references: 8602746
references: N Engl J Med. 2011 Dec 8;365(23):2188-97
references: 22150037
references: J Neuropathol Exp Neurol. 2006 Dec;65(12):1137-42
references: 17146287
references: J Neurol. 2008 Feb;255(2):305-7
references: 18004636
references: Mol Cell Proteomics. 2009 Sep;8(9):2090-101
references: 19531498
references: N Engl J Med. 2011 Oct 6;365(14):1293-303
references: 21991951
references: Annu Rev Immunol. 2013;31:635-674
references: 23330956
references: Philos Trans R Soc Lond B Biol Sci. 1999 Oct 29;354(1390):1623-34
references: 10603615
references: Brain. 2013 Jan;136(Pt 1):106-15
references: 23365093
references: Curr Top Microbiol Immunol. 2007;316:71-95
references: 17969444
references: Ann Neurol. 2011 Dec;70(6):932-42
references: 22190366
references: N Engl J Med. 2010 Feb 4;362(5):387-401
references: 20089952
references: Science. 2005 May 27;308(5726):1314-8
references: 15831717
references: J Immunol. 2002 Jul 1;169(1):548-56
references: 12077287
references: Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1245-50
references: 22128336
references: Mult Scler. 2012 Feb;18(2):143-52
references: 22312009
references: J Exp Med. 1991 Jan 1;173(1):19-24
references: 1702137
references: J Clin Invest. 2013 Mar;123(3):1192-201
references: 23454769